Abstract
In Graves disease, autoantibodies activate thyroid-stimulating hormone (TSH)1 receptor, leading to hyperthyroidism caused by increases in intracellular cAMP and thyroid hormone. We developed a nonradioactive assay to measure thyroid-stimulating immunoglobulins (TSIs).